Hapbee, Biotech Stock Review

Video: Hapbee Testimonials.

Hapbee is powered by patented ultra-low radio frequency energy (ulRFE®) technology invented by EMulate Therapeutics, Inc., a technology company based in Seattle, WA. The...

Citius Pharma (CTXR) Video Presentation.

Chairman Leonard Mazur Discusses: Mino-Lok Treatment for Infected Catheters. Novellus Stem Cell Treatment for CoronaVirus and Acute Respiratory Distress. (This is not a vaccine folks, it...

Dow 36,000 – S&P 500 4,500 – NASDAQ 15,000. Then a Crash. David Hunter.

David Hunter, chief macro strategist at Contrarian Macro Advisors. Interesting interview with David Hunter, who predicts some awful things ahead (-80% market dip). But...

Video: What to Look for in Public Company Management.

In this episode MicroCapClub interviews author and fund manager Michael Shearn. Michael discusses management teams that focus on solving it's customers problems, first and foremost. He...

Video: 2020 Year of Crisis: Markets Melt Up (Bloomberg).

https://youtu.be/eL0YyWK_pcg Ask Yourself a Question, Do I Feel Lucky?

Stand Down XI. The Best Explanation of What Lies Ahead for the Economy. And...

Brace yourself friends. Brace yourself. Dow at 26,000, Gold at $1,800, and Silver at $19 today. https://youtu.be/jsV_YXq-1x4 #Danielle DiMartino Booth

Stand Down IX: Is the Country Headed Into a Global Depression? Ray Dalio.

Q: Do you think we're headed into a global depression? A: Well, yes, but I want to be careful. The word is an evocative word... https://youtu.be/yrxYhv2O3wU?t=514
Oramed, Biotech Stock REview

Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?

New technology could revolutionize market of 500 million diabetes patients (i24 News). LIVE CHART Oramed Pharmaceuticals (ORMP) developed insulin capsule that can be consumed orally A new...
Julie R Smith, True Nature, Mitesco

True Nature|Mitesco President & COO, Julie Smith Interview.

Julie R. Smith is a seasoned senior executive and board member with more than 25 years of success spanning healthcare, technology, education and retail....
Steven Boyd, Armistice

Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).

A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied on athletic...

Latest article

Latest Research Report: $20 Price Target from Greenridge Global.

Here are four research reports below to peruse, all with price targets $20.00 or more... While we don't issue price targets, it's comforting to see...

Three More Companies Suspended by SEC!

Millions of Investor's Dollars are Being Trapped. These three companies had a combined market cap of $563 million at the time they were halted, whose...

AI Data Center Short – Jim Chanos

“If the economic life on these things is three years ... the whole economics of a lot of these deals kind of falls...